These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13873962)

  • 1. [Demonstration on a trial treatment with Euclidan injected by the intra-arterial route of severe ischemic conditions of the lower limbs].
    BRUN F; PLAUCHU G; PERRIN A
    Lyon Med; 1962 Jun; 94():1413-25. PubMed ID: 13873962
    [No Abstract]   [Full Text] [Related]  

  • 2. Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
    HAMILTON RR
    Practitioner; 1960 Mar; 184():367-9. PubMed ID: 14399278
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of a new synthetic vasodilator, Caa 40, in the treatment of chronic ulcers of the lower extremities].
    THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE JOSSERAND
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():217-21. PubMed ID: 13837804
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of nylidrin hydrochloride on the skin and muscle temperature of patients with occlusive arterial disease of the lower extremities.
    ROEDLING HA; ROTH GM; SCHIRGER A; GIFFORD RW
    Angiology; 1960 Apr; 11():130-2. PubMed ID: 14438272
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of the treatment of peripheral circulation disorders with Complamine].
    SPERLING M
    Munch Med Wochenschr; 1962 Jul; 104():1273-8. PubMed ID: 13915730
    [No Abstract]   [Full Text] [Related]  

  • 6. [The hexa-nicotinic acid ester of m-inositol in the treatment of peripheral vascular diseases. Clinical results].
    MAGLIULO V; SERRA GC
    Minerva Med; 1961 May; 52():1832-8. PubMed ID: 13765270
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the appropriate treatment of peripheral circulation disorders in private practice].
    SCHOGER-VON SCHOLZ I; SCHOGER GA
    Ther Ggw; 1960 May; 99():235-8. PubMed ID: 14443420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of long-term therapy with Complamin].
    EHRENBERG H
    Hippokrates; 1961 Dec; 32():937-40. PubMed ID: 13889493
    [No Abstract]   [Full Text] [Related]  

  • 9. [The influence on peripheral circulation disorders and on blood cholesterol of a nicotinic acid derivative (ES 304), administered in high doses].
    SIEGENTHALER P
    Praxis; 1960 Jun; 49():616-20. PubMed ID: 14446484
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medicinal treatment of peripheral blood circulation disorders].
    OSTAPOWICZ G
    Med Klin; 1956 Sep; 51(39):1637-9. PubMed ID: 13378008
    [No Abstract]   [Full Text] [Related]  

  • 11. Inositol niacinate as a peripheral vasodilator.
    LUMISH SH; BLYN C; NODINE JH
    Curr Ther Res Clin Exp; 1962 May; 4():243-8. PubMed ID: 14467334
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical contribution to the treatment of autonomic circulation disorders].
    HIRSCH W
    Med Klin; 1957 Aug; 52(35):1536-9. PubMed ID: 13482958
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy].
    STARACE G; NOFERI A; PADULA R
    Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a new vasodilator agent in management of peripheral arterial insufficiency.
    SAMUELS SS; SHAFTEL HE
    J Am Med Assoc; 1959 Sep; 171():142-5. PubMed ID: 14441294
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1].
    FERRANTE G; GRASS IM; NEGRO G
    Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372
    [No Abstract]   [Full Text] [Related]  

  • 16. A quantitative appraisal of the value of vasodilators in occlusive peripheral arterial disease.
    GILLESPIE JA
    Bull Soc Int Chir; 1962; 21():69-72. PubMed ID: 13898634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with tetranicotinoyl-fructose in the treatment of peripheral vascular diseases].
    GUERRA G
    Riforma Med; 1962 Sep; 76():966-70. PubMed ID: 13951107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic trial of a vasodilator in arteriopathy of the extremities. Evaluation of results and discussion on the use of vasodilators in arteritis].
    PIERRON J
    Mars Med; 1960; 97():641-5. PubMed ID: 14432867
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the use in medical therapy of peripheral arteriopathies of an enzymatic complex in association with a peripheral vasodilator].
    STARACE G; NOFERI A
    Minerva Cardioangiol; 1959 Oct; 7():545-50. PubMed ID: 13833816
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of peripheral vascular diseases with a new vasodilator agent].
    MARINONI E; ZUCCHI C
    Minerva Cardioangiol; 1960 Dec; 8():597-607. PubMed ID: 13766848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.